Hematologic Tumor Cell Resistance to the BCL-2 Inhibitor Venetoclax: A Product of Its Microenvironment?

about

Hematologic Tumor Cell Resistance to the BCL-2 Inhibitor Venetoclax: A Product of Its Microenvironment?

Item

http://www.wikidata.org/entity/Q58580676

description

scientific article published on 22 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Hematologic Tumor Cell Resista ...... oduct of Its Microenvironment?

@en

Hematologic Tumor Cell Resista ...... oduct of Its Microenvironment?

@nl

type

Item

label

Hematologic Tumor Cell Resista ...... oduct of Its Microenvironment?

@en

Hematologic Tumor Cell Resista ...... oduct of Its Microenvironment?

@nl

prefLabel

Hematologic Tumor Cell Resista ...... oduct of Its Microenvironment?

@en

Hematologic Tumor Cell Resista ...... oduct of Its Microenvironment?

@nl

P1476

Hematologic Tumor Cell Resista ...... oduct of Its Microenvironment?

@en

P2093

Joel D Leverson

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Programmed anuclear cell death delimits platelet life span.

Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.

P304

458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00458

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dan Cojocari

P577

2018-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30406027

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6204401

http://www.w3.org/2001/XMLSchema#string